Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer-Reference-Cited by-同舟云学术

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer

Published:2005-03 Issue:3 Volume:192 Page:813-818
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Santin Alessandro D.,Bellone Stefania,Siegel Eric R.,Palmieri Michela,Thomas Maria,Cannon Martin J.,Kay Helen H.,Roman Juan J.,Burnett Alexander,Pecorelli Sergio

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference24 articles.

1. Cancer statistic: 2003;Jemal;CA Cancer J Clin,2003

2. Two pathogenetic types of endometrial carcinoma;Bohkman;Gynecol Oncol,1983

3. Contrasts in survival of black and white cancer patients, 1960-73;Axtell;J Natl Cancer Inst,1978

4. Racial differences in survival of women with endometrial cancer;Bain;Am J Obstet Gynecol,1987

5. Endometrial cancer: stage at diagnosis and associated factors in black and white patients;Barrett;Am J Obstet Gynecol,1995

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From knowledge to advocacy: Bridging the gap between research and action;Gynecologic Oncology Reports;2024-08

2. HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls;Histopathology;2024-03-05

3. Racial Differences in Endometrial Cancer Genomics and Outcomes Using Uncseqtm Targeted DNA Sequencing;2024

4. The ErbB Signaling Network and Its Potential Role in Endometrial Cancer;Epigenomes;2023-10-01

5. In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma;Molecular Cancer Therapeutics;2023-09-07